We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 5,525 results
  1. Longitudinal metabolomics of human plasma reveal metabolic dynamics and predictive markers of antituberculosis drug-induced liver injury

    Tuberculosis (TB) remains the second leading cause of death from a single infectious agent and long-term medication could lead to antituberculosis...

    Mengjiao Li, Dan Zhang, ... Binwu Ying in Respiratory Research
    Article Open access 21 June 2024
  2. Management of type 1 immediate hypersensitivity reactions to antituberculosis drug: succesful desensitization

    Objective

    In this study, it was aimed to investigate the prevalence of type 1 hypersensitivity reaction under tuberculosis treatment and the...

    Zeynep Yegin Katran, İsmet Bulut, ... Metin Keren in Allergy, Asthma & Clinical Immunology
    Article Open access 21 November 2022
  3. Epidemiology of tuberculosis and susceptibility to antituberculosis drugs in Reunion Island

    Background

    Tuberculosis is the first fatal infectious agent in the world with 1.2 million annual deaths for 10 million cases. Little is known about...

    Moreea Loukman, Belmonte Olivier, ... Coolen-Allou Nathalie in BMC Infectious Diseases
    Article Open access 05 January 2023
  4. Synthesis and characterization of hydrazones and their transition metal complexes: antimicrobial, antituberculosis and antioxidant activity

    In the search of potential bioactive compounds, we have synthesized new Co(II), Ni(II), Cu(II) and Zn(II) metal complexes of hydrazone ligands...

    Tanisha Arora, Jai Devi, ... Swati Rani in Research on Chemical Intermediates
    Article 30 August 2023
  5. Synthesis and characterization of PANI and PANI-indole copolymer and study of their antimalarial and antituberculosis activity

    The preparation of polyaniline (PANI) and its copolymer with indole involved a chemical oxidative polymerization method, with benzene sulfonic acid...

    Purnima Chaubisa, Dharmendra Dharmendra, ... Chetna Ameta in Polymer Bulletin
    Article 06 June 2023
  6. Antituberculosis Activity and Pharmacokinetics of Polymer Conjugates of Isoniazid and Ethambutol

    Aconjugate containing isonicotinic acid hydrazide linked with a hydrazone bond (20 ± 2 mol%) and ionically bonded ethambutol (25 ± 2 mol%) was...

    Sh. A. Shomurotov, O. R. Akhmedov, ... G. Kh. Mamadullaev in Pharmaceutical Chemistry Journal
    Article 25 September 2021
  7. Investigation of antituberculosis, antimicrobial, anti-inflammatory efficacies of newly synthesized transition metal(II) complexes of hydrazone ligands: structural elucidation and theoretical studies

    Tuberculosis disease is a serious threat to humans and spreading quickly worldwide, therefore, to find a potent drug, the synthesis of hydrazone...

    Binesh Kumar, Jai Devi, ... Bharti Taxak in Scientific Reports
    Article Open access 23 September 2023
  8. Discovery and characterization of genes conferring natural resistance to the antituberculosis antibiotic capreomycin

    Metagenomic-based studies have predicted an extraordinary number of potential antibiotic-resistance genes (ARGs). These ARGs are hidden in various...

    Shu-Ing Toh, Johan Elaine Keisha, ... Chin-Yuan Chang in Communications Biology
    Article Open access 19 December 2023
  9. Naringenin protects hepato-renal tissues against antituberculosis drugs induced toxic manifestations by modulating interleukin-6, insulin like growth factor-1, biochemical and ultra-structural integrity

    Background

    The antituberculosis drugs (ATDs), isoniazid, rifampicin, pyrazinamide and ethambutol prompt extreme hepatic and renal damage during...

    Nisha Sahu, Samrat Rakshit, ... Monika Bhadauria in Molecular Biology Reports
    Article 16 November 2022
  10. Monitoring of an Antituberculosis Drug Degradation under UV Radiation

    Abstract

    Despite the fact that the detection of pharmaceutical products in the various water systems is a subject, which does not date from today,...

    H. Kais, N. Yeddou Mezenner, ... A. Hamadi in Russian Journal of Physical Chemistry A
    Article 05 October 2022
  11. Antibiotic Adjuvant 4-Hexylresorcinol Enhances the Efficiency of Antituberculosis Drugs

    We studied the possibility of using 4-hexylresorcinol to increase the efficiency of anti-mycobacterial chemotherapy. In an in vitro experiment,...

    Yu. A. Nikolaev, T. N. Mukhina, ... O. Yu. Manzenyuk in Bulletin of Experimental Biology and Medicine
    Article 01 February 2024
  12. Gelatin Nanoparticles as Carrier for Effective Antituberculosis Drug Delivery in Combination Therapy

    Gelatin nanoparticles, synthesized via desolvation, serve as effective carriers for anti-tuberculosis drugs in both single and combination therapies....

    Shivang K. Desai, Smritilekha Bera, Dhananjoy Mondal in BioNanoScience
    Article 19 February 2024
  13. Dzherelo (Immunoxel) as adjunctive therapy to standard antituberculosis treatment in patients with pulmonary tuberculosis: a systematic review and meta-analysis of clinical trials

    Background

    Dzherelo (Immunoxel) is one of the few approved immunomodulators that has been shown to produce positive treatment outcomes in patients...

    Marcel Kitenge, Bessie Phiri, ... Peter S. Nyasulu in Systematic Reviews
    Article Open access 26 May 2021
  14. Discovery of novel antituberculosis agents among 3-phenyl-5-(1-phenyl-1H-[1,2,3]triazol-4-yl)-[1,2,4]oxadiazole derivatives targeting aminoacyl-tRNA synthetases

    Antibiotic resistance is a major problem of tuberculosis treatment. This provides the stimulus for the search of novel molecular targets and...

    Mariia Yu. Rybak, Anatoliy O. Balanda, ... Galyna P. Volynets in Scientific Reports
    Article Open access 30 March 2021
  15. Mechanisms of Mycobacterium tuberculosis Drug Resistance

    Abstract

    The review presents the results of investigations of the mechanisms of action of long-used and new antituberculosis drugs, and information...

    Article 01 March 2024
  16. Overview of Drug-Resistant Pulmonary Tuberculosis

    Drug resistance in Mycobacterium pulmonary tuberculosis is defined as in vitro tests that confirm that Mycobacterium pulmonary tuberculosis has...
    Yun-xia Wang, Juan-juan Zhang, ... Pu-Xuan Lu in Diagnostic Imaging of Drug Resistant Pulmonary Tuberculosis
    Chapter 2023
  17. Lipophilic Imidazolylpyridines with Antimicrobial Activity

    The reaction of nicotinic and isonicotinic propargylamides with lipophilic aliphatic amines yielded a series of 3- or 4-(5-methyl-1 H -imidazol-2-yl)pyr...

    T. S. Vedekhina, M. Z. Dogonadze, ... A. Yu. Lukin in Pharmaceutical Chemistry Journal
    Article 01 September 2023
  18. Polymer Complexes of Rifampicin Antibiotic Based on poly(2-acrylamido-2-methylpropanesulfonic Acid)

    Polymer complexes of the homopolymer of 2-acrylamido-2-methylpropanesulfonic acid containing 18.9 – 35.3 wt% of the antituberculosis antibiotic...

    M. V. Solovskii, M. S. Borisenko, ... E. B. Tarabukina in Pharmaceutical Chemistry Journal
    Article 12 November 2022
  19. Factors associated with adverse drug reactions or death in very elderly hospitalized patients with pulmonary tuberculosis

    The aging of patients with tuberculosis and better therapeutic management for them are recent concerns. This study aimed to identify risk factors for...

    Mitsuaki Yagi, Yuichiro Shindo, ... Kenji Ogawa in Scientific Reports
    Article Open access 26 April 2023
  20. Anterior debridement combined with autogenous iliac bone graft fusion for the treatment of lower cervical tuberculosis: a multicenter retrospective study

    Background

    This study aimed to analyze the clinical efficacy of one-stage anterior debridement of lower cervical tuberculosis using iliac crest bone...

    ** **a, Pengfei Tao, ... Feifei Pu in Journal of Orthopaedics and Traumatology
    Article Open access 14 September 2023
Did you find what you were looking for? Share feedback.